Drugs News and Research

RSS

HIV patients susceptible to psychosocial challenges like depression and anxiety, finds study

The COVID-19 pandemic had substantial psychological impacts on the nation and around the world. New research shows patients with HIV were particularly susceptible to psychosocial challenges like depression, anxiety, substance abuse, loneliness and more.

30 Jun 2023

Cyanotriazole compounds can selectively and rapidly kill trypanosome parasites, study shows

Cyanotriazole compounds are fast-acting topoisomerase II poisons that can selectively and rapidly kill trypanosome parasites that cause Chagas disease and African sleeping sickness, according to a new study.

29 Jun 2023

UW Medicine reaffirms support for access to abortion care

The Supreme Court decision in Dobbs v. Jackson Women's Health Organization, overturning Roe v. Wade and Planned Parenthood v. Casey, has had significant impacts nationally on healthcare justice, affecting the health, financial stability and opportunity for many people across the country.

29 Jun 2023

McMaster research opens new possibilities to help people maintain weight loss after dieting

Researchers led by McMaster University professor Gregory Steinberg and postdoctoral research fellow Dongdong Wang have uncovered a key mechanism for promoting weight loss and maintaining the burning of calories during dieting.

29 Jun 2023

Adverse childhood experiences linked to highest risk for problematic adolescent cannabis use

Young people who are exposed to adverse childhood experiences between the ages of 0 – 12 years, including parental drug misuse, are at highest risk for developing problematic adolescent cannabis use as teenagers, according to a new study.

29 Jun 2023

MDXX drugs: A promising new therapy for autism spectrum disorder

A new review in the peer-reviewed journal Psychedelic Medicine describes the complex pharmacology of methylenedioxy amphetamine analogs, or MDXX drugs, and how they may help treat autism spectrum disorder (ASD).

29 Jun 2023

eTRANSAFE: European project to share data on the safety of medicines

eTRANSAFE, the European project to share data on the safety of medicines, has come to fruition. On a single platform, the project has integrated data from more than 10,000 pharmacological studies by reference pharmaceutical companies, from a dozen databases that amass public and private information of clinical and preclinical studies.

29 Jun 2023

The protective effects of extra virgin olive oil on disease risk factors

Researchers conducted a systematic review to consolidate recent evidence on the preventive benefits of extra virgin olive oil on disease risk factors.

29 Jun 2023

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Researchers performed a phase II randomized clinical trial (RCT).

29 Jun 2023

Understanding the biological effects of SARS-CoV-2 persistence in children

Researchers analyzed the most recent knowledge about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

29 Jun 2023

Vitamin D supplements may reduce risk of heart attacks in older adults

Vitamin D supplements may reduce the risk of major cardiovascular events such as heart attacks among people aged over 60, finds a clinical trial published by The BMJ today.

28 Jun 2023

Trial shows no benefit of prescribing an opioid for people with acute back or neck pain

Opioid pain-relieving medicines are not more effective than a placebo in relieving acute back and neck pain and may even cause harm, according to a world-first trial led by the University of Sydney.

28 Jun 2023

Novel method to deliver drugs into inner ear restores hearing in deaf mice

An international team of researchers has developed a new method to deliver drugs into the inner ear. The discovery was possible by harnessing the natural flow of fluids in the brain and employing a little understood backdoor into the cochlea.

28 Jun 2023

First genetic marker for MS severity discovered

Scientists identify the first genetic marker for MS severity, opening the door to preventing long-term disability.

28 Jun 2023

Pyroptosis: A potential therapeutic target for lung cancer

Lung cancer, one of the most aggressive forms of cancer, continues to be a leading cause of death worldwide. Although several new therapies have been developed for this disease, it has a poor prognosis in its advanced stages.

28 Jun 2023

Susan G. Komen awards $19.3 million to advance precision medicine and improve breast cancer outcomes

Susan G. Komen, the world's leading breast cancer organization, today announced the awarding of 49 new grants to researchers at 28 leading institutions in the U.S.

28 Jun 2023

SickKids researchers discover new way to attack treatment-resistant TB infections

In the face of growing antibiotic resistance among bacterial infections, scientists at The Hospital for Sick Children (SickKids) have delved into the molecular science behind treatment-resistant tuberculosis.

28 Jun 2023

Study identifies genetic variant that increases disease severity in multiple sclerosis

A study of more than 22,000 people with multiple sclerosis (MS) has for the first time identified a genetic variant associated with faster progression of the disease, an accumulation of disability that can rob patients of their mobility and independence over time.

28 Jun 2023

Novel drug combination shows promise in treating pancreatic cancer

Mutations in the KRAS gene are the major driver of pancreatic cancer. The resulting protein controls multiple signaling pathways involved in cell growth and survival. In cancer, the gene is mutated to be permanently "on," driving cells to excessively multiply and form tumors.

28 Jun 2023

Single-cell transcriptomic analysis reveals specific cellular signatures for kidney transplant rejection

Imagine a day when a urine test could inform a doctor precisely why a kidney transplant patient was experiencing organ rejection and suggest the best medication for specifically addressing the problem.

28 Jun 2023

Drugs News and Research

HIV patients susceptible to psychosocial challenges like depression and anxiety, finds study

Cyanotriazole compounds can selectively and rapidly kill trypanosome parasites, study shows

UW Medicine reaffirms support for access to abortion care

McMaster research opens new possibilities to help people maintain weight loss after dieting

Adverse childhood experiences linked to highest risk for problematic adolescent cannabis use

MDXX drugs: A promising new therapy for autism spectrum disorder

eTRANSAFE: European project to share data on the safety of medicines

The protective effects of extra virgin olive oil on disease risk factors

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Understanding the biological effects of SARS-CoV-2 persistence in children

Vitamin D supplements may reduce risk of heart attacks in older adults

Trial shows no benefit of prescribing an opioid for people with acute back or neck pain

Novel method to deliver drugs into inner ear restores hearing in deaf mice

First genetic marker for MS severity discovered

Pyroptosis: A potential therapeutic target for lung cancer

Susan G. Komen awards $19.3 million to advance precision medicine and improve breast cancer outcomes

SickKids researchers discover new way to attack treatment-resistant TB infections

Study identifies genetic variant that increases disease severity in multiple sclerosis

Novel drug combination shows promise in treating pancreatic cancer

Single-cell transcriptomic analysis reveals specific cellular signatures for kidney transplant rejection

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News